Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer

Molecular profiling of Pancreatic Ductal Adenocarcinoma (PDA), based on transcriptomic analyses, identifies two main prognostic subtypes (basal-like and classical), but does not allow personalized first-line treatment. To date, tumors have not been profiled based on protein synthesis rates, yet the step of mRNA translation is highly deregulated in both PDA cancer cells and their microenvironment. Using a collection of twenty-seven pancreatic Patient-Derived Xenografts (PDX), we performed genome-wide analysis of translated mRNA (translatome). Unsupervised bioinformatics analysis revealed a new tumor subtype harboring a low protein synthesis rate, but associated with a robust translation of mRNAs encoding effectors of the integrated stress response (ISR), including the transcription factor ATF4. Functional characterization of the “ISR-activated” human cancer cells revealed a high resistance to drugs, low autophagic capacities, and importantly, metabolic impairments in the serine synthesis and transsulfuration pathways. Overall, our study highlights the strength of translatomic profiling on PDA, which here revealed an unforeseen drug-resistant cancer cell phenotype, whose auxotrophy to both serine and cysteine may be amenable to targeted therapy.

[1]  J. Mancias,et al.  Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer , 2020, Cell.

[2]  L. Matrisian,et al.  Projection of cancer incidence and death to 2040 in the US: Impact of cancer screening and a changing demographic. , 2020 .

[3]  N. Malats,et al.  Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses , 2020, Gut.

[4]  E. O’Reilly,et al.  New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma , 2020, Drugs.

[5]  Stephen A. Sastra,et al.  Cysteine depletion induces pancreatic tumor ferroptosis in mice , 2020, Science.

[6]  T. Nägele,et al.  Inverse Data-Driven Modeling and Multiomics Analysis Reveals Phgdh as a Metabolic Checkpoint of Macrophage Polarization and Proliferation , 2019, Cell reports.

[7]  C. Tournigand,et al.  Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial. , 2019, European journal of cancer.

[8]  N. Sonenberg,et al.  eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer. , 2019, JCI insight.

[9]  E. Ruppin,et al.  Translational Reprogramming Marks Adaptation to Asparagine Restriction in Cancer , 2019, Nature Cell Biology.

[10]  S. Sivanand,et al.  Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting. , 2019, Cell metabolism.

[11]  Joon-Oh Park,et al.  Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. , 2019, The New England journal of medicine.

[12]  Dae Cheon Jeong,et al.  Prognostic significance of EIF4G1 in patients with pancreatic ductal adenocarcinoma , 2019, OncoTargets and therapy.

[13]  O. Larsson,et al.  Generally applicable transcriptome-wide analysis of translation using anota2seq , 2019, Nucleic acids research.

[14]  Jeffrey E. Lee,et al.  Expression and Clinical Significance of Protein Kinase RNA–Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2&agr; in Pancreatic Ductal Adenocarcinoma , 2019, Pancreas.

[15]  P. Walter,et al.  Small molecule ISRIB suppresses the integrated stress response within a defined window of activation , 2019, Proceedings of the National Academy of Sciences.

[16]  R. Nishigaki,et al.  Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response , 2018, Proceedings of the National Academy of Sciences.

[17]  L. Parts,et al.  Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B , 2018, Science.

[18]  Kwok-Kin Wong,et al.  Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms. , 2018, Cancer discovery.

[19]  O. Elroy-Stein,et al.  A Unique ISR Program Determines Cellular Responses to Chronic Stress. , 2017, Molecular cell.

[20]  J. Iovanna,et al.  Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts , 2017, Cell reports.

[21]  Jingqin Luo,et al.  Tissue‐Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression , 2017, Immunity.

[22]  M. V. Vander Heiden,et al.  Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions , 2017, Nature Communications.

[23]  S. Gallinger,et al.  Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer , 2017, British Journal of Cancer.

[24]  O. Larsson,et al.  Polysome-profiling in small tissue samples , 2017, bioRxiv.

[25]  Agnieszka K Witkiewicz,et al.  Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility , 2017, Gut.

[26]  Jingqin Luo,et al.  Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression. , 2017, Immunity.

[27]  Mila Ljujic,et al.  The integrated stress response , 2016, EMBO reports.

[28]  Karen H. Vousden,et al.  Serine and one-carbon metabolism in cancer , 2016, Nature Reviews Cancer.

[29]  Masato Miyake,et al.  Integrated stress response of vertebrates is regulated by four eIF2α kinases , 2016, Scientific Reports.

[30]  Brandon Da Silva,et al.  NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer , 2016, Cell.

[31]  P. Abbe,et al.  Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance. , 2016, Cancer cell.

[32]  Nicholas T. Ingolia.  Ribosome Footprint Profiling of Translation throughout the Genome , 2016, Cell.

[33]  Christian M. Metallo,et al.  Branched chain amino acid catabolism fuels adipocyte differentiation and lipogenesis , 2015, Nature chemical biology.

[34]  H. A. King,et al.  Translatome profiling: methods for genome-scale analysis of mRNA translation. , 2014, Briefings in functional genomics.

[35]  P. Abbe,et al.  Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance. , 2016, Cancer cell.

[36]  M. Korc,et al.  Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma , 2015, Cell Death and Disease.

[37]  Jen Jen Yeh,et al.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma , 2015, Nature Genetics.

[38]  N. Sonenberg,et al.  Targeting the translation machinery in cancer , 2015, Nature Reviews Drug Discovery.

[39]  C. Weekes,et al.  Nanoparticle albumin-bound (nab)-paclitaxel for the treatment of pancreas ductal adenocarcinoma , 2015 .

[40]  K. Vousden,et al.  Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. , 2014, Cell reports.

[41]  Amy Y. M. Au,et al.  Targeting mTOR dependency in pancreatic cancer , 2014, Gut.

[42]  J. Pelletier,et al.  Pancreatic tumours escape from translational control through 4E-BP1 loss , 2014, Oncogene.

[43]  徐凤鸣.  Branched chain amino acid , 2013 .

[44]  V. Carraro,et al.  The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression , 2013, Nucleic acids research.

[45]  Brent M. Sanders,et al.  Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. , 2013, Cancer research.

[46]  J. Scoazec,et al.  Pancreatic Tumor Sensitivity to Plasma L-Asparagine Starvation , 2012, Pancreas.

[47]  J. Rabinowitz,et al.  Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation , 2012, Proceedings of the National Academy of Sciences.

[48]  Scott E. Kern,et al.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.

[49]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[50]  M. Goggins,et al.  Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. , 2003, Journal of the National Cancer Institute.